ஜேன் வாலண்டே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Child at Royal Manchester Children’s Hospital is first in north to receive £1.79m life-saving gene-therapy drug
Zolgensma is a one-off gene therapy that treats Spinal Muscular Atrophy (SMA).
direct to your inboxInvalid EmailSomething went wrong, please try again later.
Click here
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
A patient at Royal Manchester Children’s Hospital is the first in the north of England to receive a potentially life-saving drug on the ....

City Of , United Kingdom , Arthur Morgan , Reece Morgan , Jane Valente , Gary Mccullagh , Disciplinary Team , Manchester University , University Hospitals Bristol , Royal Manchester Children , Spinal Muscular Atrophy , Novartis Gene Therapies , Manchester Children , Evelina London Children , Advanced Therapeutic Medicinal Products , Consultant Paediatric Neurologist , Medical Director , North West , London Children , Great Ormond Street Hospital , Hospitals Bristol , Multi Disciplinary Team , Neuromuscular Centres , Royal Manchester Childrens Hospital , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் ,